Since ERK1/2 and p38 have been shown as the major upstream regulators of phospho-MNK1/2 [38, 39], elevation of phospho-MNK1/2 in sarcoma cells is likely resulted from hyper-activation of mitogen-activated protein kinases in cancerous state. This evidence concerns the gene MKNK1 and sarcoma.